Overview of economic evaluation of positron-emission tomography

European Journal of Health Economics

Volumn 3, Issue 1, 2002, Pages 59-65

  Muller A ^a   Stratmann Schöne, Diana ^a   Klose, T ^a   Leidl, R ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Cost effectiveness; Health technology assessment report; Positron emission tomography

Indexed keywords

CARDIOLOGY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; GERMANY; NEUROLOGY; ONCOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSYCHIATRY; REVIEW; TECHNOLOGY;

EID: 23944462821     PISSN: 16187598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10198-001-0084-3     Document Type: Review

References (34)

1. Klutmann S, Bohuslavizki KH, Brenner W, et al (1999) Positron emission tomography (PET) in clinical routine. Radiol Oncol 33:111-117
2. Reske SN (1998) Positronen-Emissions-Tomographie in der Onkologie. Dtsch Arztebl 30:A1847-1849
3. Conti PS, Keppler JS, Halls JM (1994) Positron emission tomography: a financial and operational analysis. AJR Am J Roentgenol 162:1279-1286
4. Lottes G, Schober O (2000) Costs of F-18-FDG PET with a satellite concept: update. Nuklearmedizin 39:72-76
5. Müller A, Stratmann-Schöne D, Klose T, Leidl R (2001) Ökonomische Evaluationen der Positronen-Emissions-Tomographie- ein gesundheitsökonomischer HTA-Bericht. Health Technology Assessment, vol 20. Nomos: Baden-Baden
6. Leidl R, Graf von der Schulenburg JM, Wasem J (1999) Ansätze und Methoden der ökonomischen Evaluation - eine internationale Perspektive. Health Technology Assessment, vol 9. Nomos: Baden-Baden
7. Adler LP, Cascade E, Crowe J (1994) Clinical application and economic implications of PET in the assessment of axillary lymph node involvement in breast cancer: a retrospective study. Publ no CE-breast 94.001. Institute for Clinical PET
8. Adler LP, Faulhaber PF, Schnur KC, Al-Kasi NL Shenk RR (1997) Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET. Radiology 203:323-327
9. Coleman RE, Cascade E, Gupta NC, Lawson M, Patz E, Rubin RJ (1994) Clinical application and economic implications of PET in the assessment of solitary pulmonary nodules: a retrospective study. Publ no CE-SPN 94.001. Institute for Clinical PET
10. Coleman RE, Cascade E, Gupta NC, Lawson M, Patz E, Rubin RJ (1995) Untersuchungen von solitären Lungenknoten mit PET. Electromedica 63:48-52
11. Dietlein M, Weber K, Gandjour A, Moka D, Theissen P, Lauterbach KW, Schicha H (2000) Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany. Eur J Nucl Med 27:1441-1456
12. ECRI (1998) Positron emission tomography (PET) for the diagnosis and staging of non-small-cell lung cancer. II. Cost-effectiveness analysis. No 73. Health Technology Assessment Information Service
13. Gambhir SS, Hoh CK, Phelps ME, Madar I, Maddahi J (1996) Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med 7:1428-1436
14. Gambhir SS, Shepherd JE, Shah BD, et al (1998) Analytical decision model for the cost-effective management of solitary pulmonary nodules. J Clin Oncol 16:2113-2125
15. Hoh CK, Glaspy J, Rosen P, et al (1997) Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med 38:343-348
16. Klose T, Leidl R, Buchmann I, Brambs HJ, Reske SN (2000) Primary staging of lymphomas: cost-effectiveness of FDG-PET versus computed tomography. Eur J Nucl Med 27:1457-1464
17. Kosuda S, Ichihara K, Watanabe M, Kobayashi H, Kusano S (2000) Decision-tree sensitivity analysis for cost-effectiveness of chest 2-Fluoro-2-D-[18 F]Fluorodeoxyglucose positron emission tomography in patients with pulmonary nodules (non-small cell lung carcinoma) in Japan. Chest 117:346-353
18. Larson SM, Cohen A, Cascade E, et al (1994) Clinical application and economic implications of PET in the assessment of colorectal cancer recurrence: a retrospective study. Publ no CE-color 94.0001. Institute for Clinical PET
19. Scott WJ, Shepherd J, Gambhir SS (1998) Cost-effectiveness of FDG-PET for staging non-small cell lung cancer: a decision analysis. Ann Thorac Surg 66:1876-1883
20. Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK (1996) Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol 23:737-743
21. Valk PE, Abella-Columna E, Haseman MK, et al (1999) Whole-body PET imaging with [18F]flu-orodeoxyglucose in management of recurrent colorectal cancer. Arch Surg 134:503-513
22. Schulthess GK von, Steinert HC, Dummer R, Weder W (1998) Cost-effectiveness of whole-body PET imaging in non-small cell lung cancer and malignant melanoma. Acad Radiol 5[Suppl 2]:S300-302
23. Bairy Merez CN, Berman DS (1997) Imaging techniques for coronary artery disease: current status and future directions. Clin Cardiol 20:526-532
24. Besozzi MC, Alagona P, Hunter K, Maddahi J, Vohs C, Young C (1994) Clinical application and economic implications of PET in the assessment of myocardial viability: a retrospective study. Publ no CE-cardiology-94.001. Institute for Clinical PET
25. Garber AM, Solomon NA (1999) Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 130:719-728
26. Gould KL, Goldstein RA, Mullani NA (1989) Economic analysis of clinical positron emission tomography of the heart with rubidium-82. J Nucl Med 30:707-717
27. Hunink MG (1995) Positron emission tomography compared to single photon emission tomography in the evaluation of myocardial viability: a preliminary cost-effectiveness analysis. In: Van der Wall, et al (eds) Cardiac positron emission tomography. Kluwer, Amsterdam, pp 97-102
28. Maddahi J, Gambhir SS (1997) Cost-effective selection of patients for coronary angiography." J Nucl Cardiol 4:141-151
29. Patterson RE, Horowitz SF, Eisner RL (1994) Comparison of modalities to diagnose coronary artery disease. Semin Nucl Med 24:286-310
30. Patterson RE, Eisner RL, Horowitz SF (1995) Comparison of cost-effectiveness and utility of exercise ECG, single photon emission computed tomography, positron emission tomography, and coronary angiography for diagnosis of coronary artery disease. Circulation 91:54-65
31. Derdeyn CP, Gage BF, Grubb RL, Powers WJ (2000) Cost-effectiveness analysis of therapy for symptomatic carotid occlusion: PET screening before selective extracranial-to-intracranial bypass versus medical treatment. J Nucl Med 41:800-807
32. Robert G, Milne R (1999) Positron emission tomography: establishing priorities for health technology assessment. Health Technology Assessment 3
33. Kuwert T, Matheja P, Schober O (1996) Effektivität der Diagnostik mit PET und SPECT bei degenerativen Hirnerkrankungen und Hirntumoren. Nuklearmediziner 1:51-59
34. Welte R, Leidl R (1999) Übertragung der Ergebnisse ökonomischer Evaluationsstudien aus dem Ausland auf Deutschland: Probleme und Lösungsansätze. Iln: Leidl R, Schulenburg JM, Wasem J (eds) Ansätze und Methoden der ökonomischen Evaluation - eine internationale Perspektive. Nomos: Baden-Baden, pp 171-202